Assessing the utilization of antimicrobial agents in pediatric pneumonia during the era of the 13-valent pneumococcal conjugate vaccine: A retrospective, single-center study

CONCLUSION: After the introduction of PCV13 in Taiwan, no decrease in antibiotic use has been observed among children aged 6 months-3 years with a discharge diagnosis of bronchopneumonia and pneumonia.PMID:37758541 | DOI:10.1016/j.jmii.2023.09.001
Source: Journal of Microbiology, Immunology, and Infection - Category: Microbiology Authors: Source Type: research